Anthropic begins its own "drug discovery activities"; acquires a biotech company with 1 employee, advances research for treatments for rare pediatric diseases
Key point
Anthropic announced on October 27 (local time) that it is advancing drug discovery activities within the company, targeting rare pediatric muscular dystrophy and others. It acquired a company where 1 employee had been conducting experiments with 11 external research institutions using the AI "Claude" and took over the research.
Anthropic announced on October 27 (local time) that it is advancing drug discovery activities within the company, targeting rare pediatric muscular dystrophy and others.
The company acquired a company where 1 employee had been conducting experiments with 11 external research institutions using the AI "Claude" and took over the research.
This item is a summary. The full, checkable version is at the original source:
Read the original at ITmedia NEWS ↗